BAYER HLTHCARE FDA Approval NDA 021258

NDA 021258

BAYER HLTHCARE

FDA Drug Application

Application #021258

Documents

Letter2003-11-28
Letter2005-06-24
Letter2013-10-11
Review2006-06-07
Label2004-04-01
Label2005-06-24
Label2013-10-17
Label2017-11-02
Letter2021-10-12
Letter2021-11-16
Label2021-11-16

Application Sponsors

NDA 021258BAYER HLTHCARE

Marketing Status

Prescription001

Application Products

001FILM, EXTENDED RELEASE;TRANSDERMAL0.045MG/24HR;0.015MG/24HR1CLIMARA PROESTRADIOL; LEVONORGESTREL

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2003-11-21STANDARD
LABELING; LabelingSUPPL3AP2005-06-22STANDARD
LABELING; LabelingSUPPL6AP2013-10-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2016-03-08STANDARD
LABELING; LabelingSUPPL11AP2017-11-01STANDARD
LABELING; LabelingSUPPL12AP2021-11-15STANDARD
LABELING; LabelingSUPPL13AP2021-10-07STANDARD

Submissions Property Types

SUPPL6Null7
SUPPL10Null0
SUPPL11Null15
SUPPL12Null6
SUPPL13Null15

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21258
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.